Leucine

Leucine

SCHEMBL3160921

CC(=O)F.CC(C)C[C@H](N)C(=O)O.CC(C)C[C@H](N)C(=O)O.CC(C)C[C@H](N)C(=O)O

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 1/20 0.86
▸ SLC1A2 P43004 7/20 0.65
▸ SLC1A3 P43003 6/20 0.65
▸ SLC1A1 P43005 7/20 0.56
▸ GRIK1 P39086 9/20 0.48
▸ GRIK2 Q13002 6/20 0.47
▸ RNPEP Q9H4A4 1/20 0.44
▸ GRIA2 P42262 2/20 0.44
▸ GRIA4 P48058 2/20 0.44
▸ GRIK3 Q13003 2/20 0.44
▸ GRIK5 Q16478 2/20 0.44
▸ GRIA1 P42261 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leucine SCHEMBL30032426 0.93 SLC7A5 (0.90) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL30323638 0.93 SLC7A5 (0.90) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL27409567 0.93 SLC7A5 (0.90) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL8568063 0.93 SLC7A5 (1.00) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL8568060 0.93 SLC7A5 (1.00) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL25241602 0.93 SLC7A5 (1.00) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL2478164 0.93 SLC7A5 (1.00) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL175940 0.93 SLC7A5 (1.00) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL20362356 0.93 — —
D-Leucine SCHEMBL42012 0.93 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1276895-B1 METHOD FOR THE IDENTIFICATION OF ACTIVE SITE PROTEASE INACTIVATORS UNIV GEORGIA (US) 2010-03-17 — — EP disclosed
EP-1379634-A1 ACTIVE SITE INACTIVATORS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2004-01-14 — — EP disclosed
US-20030077653-A1 Method for the identification of active site protease inactivators THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2003-04-24 — — US disclosed
WO-2002086115-A1 ACTIVE SITE INACTIVATORS THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2002-10-31 — — WO disclosed
Send feedback